FDA Archives | Â鶹ֱ²¥ & Lardner LLP Legal services in Boston, Massachusetts Thu, 06 Feb 2025 18:11:51 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.4 /wp-content/uploads/2024/11/cropped-Â鶹ֱ²¥-Favicon-1-32x32.png FDA Archives | Â鶹ֱ²¥ & Lardner LLP 32 32 Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 /insights/publications/2023/03/personalized-medicine-fda-scope-progress-2022/ Tue, 14 Mar 2023 05:00:00 +0000 The post Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> Personalized Medicine: 2021 FDA Guideposts for Progress – Focus On Diagnostics /insights/publications/2022/03/personalized-medicine-2021-fda-focus-diagnostics/ Fri, 11 Mar 2022 05:00:00 +0000 https://foley.com/insights/publications/2022/03/personalized-medicine-2021-fda-focus-diagnostics/ The post Personalized Medicine: 2021 FDA Guideposts for Progress – Focus On Diagnostics appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Personalized Medicine: 2021 FDA Guideposts for Progress – Focus On Diagnostics appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> Personalized Medicine: 2021 FDA Guideposts for Progress – Focus on Therapeutics /insights/publications/2022/03/personalized-medicine-2021-fda-guideposts-progress/ Thu, 03 Mar 2022 05:00:00 +0000 The post Personalized Medicine: 2021 FDA Guideposts for Progress – Focus on Therapeutics appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Personalized Medicine: 2021 FDA Guideposts for Progress – Focus on Therapeutics appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic /insights/publications/2020/07/coronavirus-innovation-guideposts-eve-pandemic/ Thu, 30 Jul 2020 05:00:00 +0000 https://foley.com/insights/publications/2020/07/coronavirus-innovation-guideposts-eve-pandemic/ The post Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> Collaborative Review of Scientific Evidence Announced By FDA /insights/publications/2020/03/collaborative-review-scientific-evidence-by-fda/ Mon, 09 Mar 2020 05:00:00 +0000 https://foley.com/insights/publications/2020/03/collaborative-review-scientific-evidence-by-fda/ The post Collaborative Review of Scientific Evidence Announced By FDA appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Collaborative Review of Scientific Evidence Announced By FDA appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> 2019 FDA Precision Medicine Approvals: Progress At FDA /insights/publications/2020/02/2019-fda-precision-medicine-approvals-progress/ Mon, 24 Feb 2020 05:00:00 +0000 The post 2019 FDA Precision Medicine Approvals: Progress At FDA appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post 2019 FDA Precision Medicine Approvals: Progress At FDA appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> The Era of Personalized Medicine Has Arrived – PMC’s Annual Progress and Outlook Report /insights/publications/2019/08/the-era-of-personalized-medicine-has-arrived/ Mon, 26 Aug 2019 05:00:00 +0000 https://foley.com/insights/publications/2019/08/the-era-of-personalized-medicine-has-arrived/ The post The Era of Personalized Medicine Has Arrived – PMC’s Annual Progress and Outlook Report appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post The Era of Personalized Medicine Has Arrived – PMC’s Annual Progress and Outlook Report appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> Over 30% of New Drug Approvals in 2017 were Personalized Medicines /insights/publications/2018/02/over-30-of-new-drug-approvals-in-2017-were-persona/ Tue, 20 Feb 2018 05:00:00 +0000 The post Over 30% of New Drug Approvals in 2017 were Personalized Medicines appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Over 30% of New Drug Approvals in 2017 were Personalized Medicines appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> FDA Approves Companion Dx for PD-1 Inhibitor /insights/publications/2017/10/fda-approves-companion-dx-for-pd1-inhibitor/ Wed, 11 Oct 2017 05:00:00 +0000 The post FDA Approves Companion Dx for PD-1 Inhibitor appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post FDA Approves Companion Dx for PD-1 Inhibitor appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]> Seven Key Questions in Understanding the Current Regulatory State of HCT/Ps /insights/publications/2017/03/seven-key-questions-in-understanding-the-current-r/ Mon, 20 Mar 2017 05:00:00 +0000 The post Seven Key Questions in Understanding the Current Regulatory State of HCT/Ps appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>

The post Seven Key Questions in Understanding the Current Regulatory State of HCT/Ps appeared first on Â鶹ֱ²¥ & Lardner LLP.

]]>